Raymond James Trust N.A. Intercept Pharmaceuticals, Inc. Transaction History

Raymond James Trust N.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 17, 2020	SELL	$48.35 - $118.68 $108,352 - $265,961	-2,241 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$57.36 - $124.1 $128,543 - $278,108	2,241 New	2,241 $278,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.